Bordbar Mohammad Reza, Modarresi Farzaneh, Farazi Fard Mohammad Ali, Dastsooz Hassan, Shakib Azad Nader, Faghihi Mohammad Ali
Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Center for Therapeutic Innovation, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1501 NW 10th Ave, BRB 508, Miami, FL, 33136, USA.
BMC Med Genet. 2017 May 3;18(1):49. doi: 10.1186/s12881-017-0404-9.
Hemophagocytic Lymphohistiocytosis (HLH) is a life-threatening immunodeficiency and multi-organ disease that affects people of all ages and ethnic groups. Common symptoms and signs of this disease are high fever, hepatosplenomegaly, and cytopenias. Familial form of HLH disease, which is an autosomal recessive hematological disorder is due to disease-causing mutations in several genes essential for NK and T-cell granule-mediated cytotoxic function. For an effective cytotoxic response from cytotoxic T lymphocyte or NK cell encountering an infected cell or tumor cell, different processes are required, including trafficking, docking, priming, membrane fusion, and entry of cytotoxic granules into the target cell leading to apoptosis. Therefore, genes involved in these steps play important roles in the pathogenesis of HLH disease which include PRF1, UNC13D (MUNC13-4), STX11, and STXBP2 (MUNC18-2).
Here, we report a novel missense mutation in an 8-year-old boy suffered from hepatosplenomegaly, hepatitis, epilepsy and pancytopenia. The patient was born to a first-cousin parents with no previous documented disease in his parents. To identify mutated gene in the proband, Whole Exome Sequencing (WES) utilizing next generation sequencing was used on an Illumina HiSeq 2000 platform on DNA sample from the patient. Results showed a novel deleterious homozygous missense mutation in PRF1 gene (NM_001083116: exon3: c. 1120 T > G, p.W374G) in the patient and then using Sanger sequencing it was confirmed in the proband and his parents. Since his parents were heterozygous for the identified mutation, autosomal recessive pattern of inheritance was confirmed in the family.
Our study identified a rare new pathogenic missense mutation in PRF1 gene in patient with HLH disease and it is the first report of mutation in PRF1 in Iranian patients with this disease.
噬血细胞性淋巴组织细胞增生症(HLH)是一种危及生命的免疫缺陷和多器官疾病,影响所有年龄和种族的人群。该疾病的常见症状和体征为高热、肝脾肿大和血细胞减少。家族性HLH病是一种常染色体隐性血液系统疾病,由自然杀伤细胞(NK)和T细胞颗粒介导的细胞毒性功能所必需的几个基因中的致病突变引起。为使细胞毒性T淋巴细胞或NK细胞在遇到受感染细胞或肿瘤细胞时产生有效的细胞毒性反应,需要不同的过程,包括运输、对接、启动、膜融合以及细胞毒性颗粒进入靶细胞导致凋亡。因此,参与这些步骤的基因在HLH病的发病机制中起重要作用,其中包括穿孔素1(PRF1)、UNC13D(MUNC13 - 4)、 syntaxin11(STX11)和 syntaxin binding protein 2(STXBP2,MUNC18 - 2)。
在此,我们报告一名8岁男孩患有肝脾肿大、肝炎、癫痫和全血细胞减少症,发现了一种新的错义突变。该患者的父母为近亲结婚,其父母之前无疾病记录。为鉴定先证者中的突变基因,利用下一代测序技术进行全外显子组测序(WES),在Illumina HiSeq 2000平台上对患者的DNA样本进行检测。结果显示患者的PRF1基因(NM_001083116:外显子3:c.1120 T>G,p.W374G)存在一种新的有害纯合错义突变,随后通过桑格测序在该先证者及其父母中得到证实。由于其父母为所鉴定突变的杂合子,该家族中确认了常染色体隐性遗传模式。
我们的研究在一名HLH病患者中鉴定出PRF1基因一种罕见的新致病错义突变,这是伊朗HLH病患者中PRF1基因突变的首次报告。